Mashiko Ryosuke, Hakozaki Michiyuki, Kaneuchi Yoichi, Nikaido Takuya, Matsumoto Yoshihiro
Department of Orthopaedic Surgery, Fukushima Prefectural Minami-Aizu Hospital, Fukushima, JPN.
Department of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, JPN.
Cureus. 2024 May 13;16(5):e60237. doi: 10.7759/cureus.60237. eCollection 2024 May.
Atypical fractures are gaining attention as a severe potential side effect of long-term treatment with bone-modifying agents (e.g., bisphosphonate and denosumab) for osteoporosis. Most atypical fractures occur in weight-bearing bones; the femur is the most frequent site. Atypical fractures occurring in non-weight-bearing bones are extremely rare. We describe an atypical fracture of the scapular spine in a 92-year-old Japanese woman with osteoporosis who had been treated with minodronate for ~7 years. Although the dislocation of the fracture site remained after conservative treatment, there was no obstacle to her daily life.
非典型骨折作为骨质疏松症长期使用骨改良药物(如双膦酸盐和地诺单抗)治疗的一种严重潜在副作用正受到关注。大多数非典型骨折发生在负重骨;股骨是最常见的部位。发生在非负重骨的非典型骨折极为罕见。我们描述了一名92岁患有骨质疏松症的日本女性,她接受米诺膦酸治疗约7年后发生了肩胛冈非典型骨折。尽管保守治疗后骨折部位仍有移位,但对她的日常生活并无妨碍。